123 related articles for article (PubMed ID: 29808993)
21. Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models of human papillomavirus-associated (pre)neoplastic epithelial lesions.
Hubert P; Evrard B; Maillard C; Franzen-Detrooz E; Delattre L; Foidart JM; Noël A; Boniver J; Delvenne P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4342-8. PubMed ID: 15504863
[TBL] [Abstract][Full Text] [Related]
22. An injectable thermosensitive hydrogel/nanomicelles composite for local chemo-immunotherapy in mouse model of melanoma.
Akbari V; Hejazi E; Minaiyan M; Emami J; Lavasanifar A; Rezazadeh M
J Biomater Appl; 2022 Sep; 37(3):551-562. PubMed ID: 35543695
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
[TBL] [Abstract][Full Text] [Related]
24. Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.
Slingluff CL; Petroni GR; Yamshchikov GV; Barnd DL; Eastham S; Galavotti H; Patterson JW; Deacon DH; Hibbitts S; Teates D; Neese PY; Grosh WW; Chianese-Bullock KA; Woodson EM; Wiernasz CJ; Merrill P; Gibson J; Ross M; Engelhard VH
J Clin Oncol; 2003 Nov; 21(21):4016-26. PubMed ID: 14581425
[TBL] [Abstract][Full Text] [Related]
25. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma.
Ho MY; Sun GH; Leu SJ; Ka SM; Tang SJ; Sun KH
Int J Cancer; 2008 Jul; 123(1):123-33. PubMed ID: 18386791
[TBL] [Abstract][Full Text] [Related]
26. Injectable, Pore-Forming Hydrogels for In Vivo Enrichment of Immature Dendritic Cells.
Verbeke CS; Mooney DJ
Adv Healthc Mater; 2015 Dec; 4(17):2677-87. PubMed ID: 26474318
[TBL] [Abstract][Full Text] [Related]
27. Development of immune cell delivery system using biodegradable injectable polymers for cancer immunotherapy.
Yoshizaki Y; Horii K; Murase N; Kuzuya A; Ohya Y
Int J Pharm; 2024 Mar; 652():123801. PubMed ID: 38244647
[TBL] [Abstract][Full Text] [Related]
28. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol)co-polymer.
Wang W; Deng L; Liu S; Li X; Zhao X; Hu R; Zhang J; Han H; Dong A
Acta Biomater; 2012 Nov; 8(11):3963-73. PubMed ID: 22835677
[TBL] [Abstract][Full Text] [Related]
29. [GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
He SB; Sun K; Wang L; Li DC; Zhang YY
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):410-4. PubMed ID: 20819479
[TBL] [Abstract][Full Text] [Related]
30. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
[TBL] [Abstract][Full Text] [Related]
31. Macrophage-colony stimulating factor enhances MHC-restricted presentation of exogenous antigen in dendritic cells.
Han S; Song Y; Lee YH; Lee YR; Lee CK; Cho K; Kim K
Cytokine; 2005 Dec; 32(5):187-93. PubMed ID: 16303313
[TBL] [Abstract][Full Text] [Related]
32. The efficient bovine insulin presentation capacity of bone marrow-derived macrophages activated by granulocyte-macrophage colony-stimulating factor correlates with a high level of intracellular reducing thiols.
Frosch S; Bonifas U; Eck HP; Bockstette M; Droege W; Rüde E; Reske-Kunz AB
Eur J Immunol; 1993 Jul; 23(7):1430-4. PubMed ID: 8325319
[TBL] [Abstract][Full Text] [Related]
33. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
[TBL] [Abstract][Full Text] [Related]
34. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
Wang X; Uto T; Akagi T; Akashi M; Baba M
J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
[TBL] [Abstract][Full Text] [Related]
35. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
Kass E; Panicali DL; Mazzara G; Schlom J; Greiner JW
Cancer Res; 2001 Jan; 61(1):206-14. PubMed ID: 11196163
[TBL] [Abstract][Full Text] [Related]
36. Degradation-regulated architecture of injectable smart hydrogels enhances humoral immune response and potentiates antitumor activity in human lung carcinoma.
Duong HTT; Thambi T; Yin Y; Kim SH; Nguyen TL; Phan VHG; Kim J; Jeong JH; Lee DS
Biomaterials; 2020 Feb; 230():119599. PubMed ID: 31718883
[TBL] [Abstract][Full Text] [Related]
37. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells.
Chou HY; Lin XZ; Pan WY; Wu PY; Chang CM; Lin TY; Shen HH; Tao MH
J Immunol; 2010 Nov; 185(9):5468-75. PubMed ID: 20889541
[TBL] [Abstract][Full Text] [Related]
38. Bridging the Gap between Macroscale Drug Delivery Systems and Nanomedicines: A Nanoparticle-Assembled Thermosensitive Hydrogel for Peritumoral Chemotherapy.
Huang P; Song H; Zhang Y; Liu J; Zhang J; Wang W; Liu J; Li C; Kong D
ACS Appl Mater Interfaces; 2016 Nov; 8(43):29323-29333. PubMed ID: 27731617
[TBL] [Abstract][Full Text] [Related]
39. Recombinant human granulocyte macrophage colony stimulating factor (hGM-CSF): Possibility of nanoparticle-mediated delivery in cancer immunotherapy.
Vanitha S; Chaubey N; Ghosh SS; Sanpui P
Bioengineered; 2017 Mar; 8(2):120-123. PubMed ID: 27459024
[TBL] [Abstract][Full Text] [Related]
40. Intradermal injection of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with metastatic melanoma recruits dendritic cells.
Nasi ML; Lieberman P; Busam KJ; Prieto V; Panageas KS; Lewis JJ; Houghton AN; Chapman PB
Cytokines Cell Mol Ther; 1999 Sep; 5(3):139-44. PubMed ID: 10641571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
